NorthSea Therapeutics logo

NorthSea Therapeutics

ID: 17658696

Innovative therapeutic drugs to treat inflammatory, metabolic and liver diseases.

4

Funding Rounds

$136.4m

Money raised

Overview

Innovative therapeutic drugs to treat inflammatory, metabolic and liver diseases.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company NorthSea Therapeutics has raised a total of $136.4m in funding over 4 rounds.

Key Insights:

  • NorthSea Therapeutics Series B round, January 2020: $40m
  • NorthSea Therapeutics January 2020 Series B Funding Round: $40m
  • NorthSea Therapeutics Series A round, December 2017: $29.4m
  • NorthSea Therapeutics December 2017 Series A Funding Round: $27m

Industries

NorthSea Therapeutics is active in the following industries: